Brevan Howard Capital Management’s Twist Bioscience TWST Stock Holding History

Brevan Howard Capital Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-9,836	Closed	-$485K	–	1448
2024 Q2	$485K	Buy	+9,836	New	+$401K	﹤0.01%	619
2021 Q4	–	Sell	-20,439	Closed	-$2.19M	–	39
2021 Q3	$2.19M	Sell	20,439 -2,272	-10%	-$260K	0.28%	20
2021 Q2	$3.03M	Hold	22,711	–	–	0.83%	21
2021 Q1	$2.81M	Sell	22,711 -89,289	-80%	-$13.6M	0.41%	35
2020 Q4	$15.8M	Buy	+112,000	New	+$12.4M	3.17%	9

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brevan Howard Capital Management's TWST Position: Q3 2024 in Review

Brevan Howard Capital Management sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 9,836 shares — an estimated $485K sold.

Brevan Howard Capital Management first reported a position in TWST in Q4 2020 and held it in 5 quarters. The position peaked at $15.8M in Q4 2020. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

Brevan Howard Capital Management reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
Brevan Howard Capital Management sold 9,836 Twist Bioscience shares in Q3 2024, an estimated $485K.
Brevan Howard Capital Management first reported a position in Twist Bioscience in Q4 2020 and held it in 5 quarters.
Brevan Howard Capital Management's Twist Bioscience position peaked at $15.8M in Q4 2020.
245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Brevan Howard Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.